Clinical Trial Update: A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH) [Phase 2]

View source ↗

Summary

Phase 2 CHERISH study to evaluate Aztreonam-Avibactam (ATM-AVI) for Gram-negative bacterial infections in hospitalized infants and newborns; recruitment is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacterial Infection

Drugs mentioned

• Aztreonam-Avibactam (ATM-AVI) (Aztreonam; Avibactam)

Snippet

Sponsor: Pfizer | Conditions: Gram-negative Bacterial Infection | Phase 2 | Status: RECRUITING